Print This PageBoard of Directors
Brief Biographies
- Frank V. AtLee, III
- John W. Bachmann
- Janice L. Fields
- Hugh Grant
- Arthur H. Harper
- Gwendolyn S. King
- C. Steven McMillan
- William U. Parfet
- George H. Poste, Ph. D., D.V.M.
- Robert J. Stevens
(Note: Ages as of November 1, 2006)
Frank V. AtLee III, 66, is a retired president of the former American Cyanamid Company and chairman of the former Cyanamid International. Both companies were involved in the discovery, development, manufacturing and marketing of medical and agricultural products. Mr. AtLee served Monsanto as chairman of the board and chair of the Executive Committee from June 2000 to October 2003. He was Monsanto's interim president and chief executive officer from December 2002 to May 2003. He is a member of the Audit and Finance Committee and the Science and Technology Committee. He is also on the boards of Antigenics Inc. and Nereus Pharmaceuticals Inc.
Mr. AtLee has been elected to a term that expires in 2010.
John W. Bachmann, 68, is a senior partner of Edward Jones, a major financial services firm that advises individual investors exclusively. From 1980 until 2004, Mr. Bachmann served as managing partner of Edward Jones. Mr. Bachmann was elected to the Monsanto board in May 2004 and is a member of the Audit and Finance Committee and the People and Compensation Committee. He also serves on the boards of AMR Corporation, the National Association of Securities Dealers, and the U.S. Chamber of Commerce, where he was the chairman of the board for 2004-2005.
Mr. Bachmann has been elected to a term that expires 2008.
Janice L. Fields, 52, is Executive Vice President and Chief Operating Officer of McDonald’s USA, LLC, a subsidiary of McDonald’s Corporation, the world’s leading global foodservice retailer. She served as President, McDonald’s Central Division from 2003 to 2006. Ms. Fields was elected to the Monsanto board in April 2008 and is a member of the Nominating and Corporate Governance Committee, the Public Policy and Corporate Responsibility Committee and the Science and Technology Committee.
Ms. Fields has been elected to a term that expires in 2009.
Hugh Grant, 48, is chairman of the board, president, and chief executive officer of Monsanto. He joined the former Monsanto as a product development representative for the company's agricultural business in 1981. Since 1991, he has served in a variety of management positions, most recently as executive vice president and chief operating officer. Mr. Grant chairs the Executive Committee. He also serves on the board of PPG Industries, Inc.
Mr. Grant has been elected to a term that expires in 2009.
Arthur H. Harper, 50 is Managing Partner of GenNx360 Capital Partners, a private equity firm focused on business to business companies. He served as President and Chief Executive Officer - Equipment Services Division, General Electric Corporation from 2002 to 2005 and Executive Vice President - GE Capital Services, General Electric Corporation from 2001 to 2002. Mr. Harper was elected to the Monsanto board in October 2006 and is a member of the Public Policy and Corporate Responsibility Committee and the Science and Technology Committee. He also serves on the board of Gannett Co., Inc.
Mr. Harper has been elected to a term that expires in 2010.
Gwendolyn S. King, 66, is president of Podium Prose, a speakers bureau. Mrs. King was senior vice president, corporate and public affairs, for PECO Energy Company, a diversified utility company. From 1989 through 1992, Mrs. King served as the 11th Commissioner of Social Security. In 2001, she was appointed to President George W. Bush's Commission to Strengthen Social Security. Mrs. King has served as a director on the Monsanto board since February 2001. She chairs the board's Public Policy and Corporate Responsibility Committee, and she is a member of the People and Compensation Committee, and the Nominating and Corporate Governance Committee. Mrs. King also serves on the boards of Lockheed Martin Corporation and Marsh and McLennan Companies Inc.
Mrs. King has been elected to a term that expires in 2010.
C. Steven McMillan, 60, is a retired chairman of the board and chief executive officer of Sara Lee Corporation, a global consumer packaged goods company whose brands include Sara Lee, Hillshire Farms, Earth Grains, Jimmy Dean, Douwe Egberts, Hanes, and Playtex. He has served as a director on the Monsanto board since June 2000. Mr. McMillan chairs the board's People and Compensation Committee, and he is a member of the Restricted Stock Grant Committee, the Audit and Finance Committee, and the Nominating and Corporate Governance Committee.
Mr. McMillan has been elected to a term that expires in 2009.
William U. Parfet, 59, is chairman of the board and chief executive officer of MPI Research Inc., a preclinical toxicology research laboratory. He has served as a director on the Monsanto board since June 2000. Mr. Parfet chairs the board's Audit and Finance Committee, and he is a member of the People and Compensation Committee and the Executive Committee. He also serves on the boards of Stryker Corporation and Taubman Centers, Inc.
Mr. Parfet has been elected to a term that expires in 2008.
George H. Poste, Ph. D., D.V.M., 62, is chief executive of Health Technology Networks. In May 2003, he was named director of the Arizona Biodesign Institute at Arizona State University. Dr. Poste is a member of the Defense Science Board of the U.S. Department of Defense, and he chairs that group's Task Force on Bioterrorism. He is a Distinguished Fellow at the Hoover Institution at Stanford University. Dr. Poste is also a member of the Council on Foreign Relations. He has served on the Monsanto board since February 2003, and chairs the Science and Technology Committee. He is also a member of the Public Policy and Corporate Responsibility Committee. Dr. Poste also serves on the boards of Exelixis, Inc. and Orchid Cellmark Inc.
Dr. Poste has been elected to a term that expires in 2008.
Robert J. Stevens, 55, is chairman of the board, president and chief executive officer of Lockheed Martin Corporation, a firm engaged in the research, design, development, manufacture and integration of advanced-technology systems, products and services. During 2001 and 2002, he served on President George W. Bush's Commission on the Future of the United States Aerospace Industry. Mr. Stevens has served as a director on the Monsanto board since August 2002. He chairs the board's Nominating and Corporate Governance Committee, and he is a member of the Audit and Finance Committee. He also serves as Monsanto's presiding director.
Mr. Stevens has been elected to a term that expires in 2009.
